饮食中的阿斯特拉加林通过减轻炎症和调节肠道微生物群,保护免受脂多糖诱导的肠道粘膜屏障损伤
Enhui Tang1, Huan Lin1, Yihao Yang1
1School of Public Health, Guangzhou Medical University, Guangzhou, China.
Frontiers in nutrition
|October 18, 2024
概括
素 (AS) 通过减少炎症和改善肠道微生物群,保护肠道屏障免受LPS诱导的损伤. 这种天然化合物增强了紧密结合蛋白和有益细菌,为肠道疾病提供了有前途的治疗途径.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 肠粘膜屏障 (IMB) 损伤与各种肠道疾病有关.
- 阿斯特拉加林 (AS) 是一种植物衍生的黄胺,具有抗氧化和抗炎性质.
- AS在管理某些肠道疾病方面显示出潜力.
研究的目的:
- 为了研究阿斯特拉加林 (AS) 对肠粘膜屏障的保护作用.
- 阐明AS在小鼠中减轻脂聚糖 (LPS) 诱导的IMB损伤的基础机制.
主要方法:
- 小鼠接受了为期7天的AS治疗方案.
- 用LPS诱导IMB损伤. LPS被用于诱导IMB损伤.
- 评估了肠道病理,血清炎症因子,紧结蛋白和肠道微生物群.
主要成果:
- 治疗AS增强了小肠形态和IMB功能.
- 观察到紧结蛋白 (ZO-1,Claudin-1) 和MUC2粘蛋白的表达升高.
- AS降低了促炎性细胞因子 (IL-6,IL-1β,TNF-α) 和调节了肠道微生物群组成,增加了有益细菌和减少了有害细菌.
结论:
- 阿斯特拉加林减轻了LPS诱导的肠粘膜屏障损伤.
- AS通过减少炎症和调节肠道微生物群来起作用.
相关概念视频
Mucosal Barrier of the Stomach
537
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
537
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
399
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
399
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
371
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
371
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356


